Social Icons

Showing posts with label Bullion Premium. Show all posts
Showing posts with label Bullion Premium. Show all posts

Wednesday, 9 May 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

CAPITALSTARS NIFTY FUTURES & BANK NIFTY FUTURES OVERVIEWS 09 MAY 2018

capitalstars
CS OPENING BELL:
NIFTY SPOT DOWN 7 @ 10709
SENSEX UP 8 @ 35221
BANK NIFTY FUTURES DOWN 33  @ 26009
HAPPY TRADING!!!!!!!!!!!


CS NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH
RES2: 10850
RES 1:10770
SUP1:10650
SUP2:10600


CS BANK NIFTY FUTURES (MAY ) OVERVIEW

TREND BEARISH
RES 2: 26250
RES 1: 26150
SUP1: 25900
SUP2: 25800

visit us: www.capitalstars.com/



call on:9977499927

O731-6690000


Get more details here:-

* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.



CapitalStars Investment Adviser: SEBI Registration Number: INA000001647



Tuesday, 30 January 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

Capitalstars Updates: Top Corporate News :- 30 Jan 2018

Capitalstars Updates:  Top Corporate News

Top Headlines Of The Day:- 30 Jan 2018

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets
KPIT and Birlasoft to come together to create two entities
Mylan and Biocon receive positive CHMP opinion for Insulin Glargine
Amber Enterprises lists at 38% premium to issue price
HCL Tech gets 5-year order from Cadent for IT Infra services

Jubilant receives ANDA approval for Clonidine Hydrochloride ER Tablets
Jubilant Life Sciences has announced that its material wholly owned subsidiary Jubilant Pharma Limited has received Abbreviated New Drug Application (ANDA) final approval for Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg. This is a generic version of Kapvay of Concordia. It is used for the treatment of attention deficit hyperactivity disorder (ADHD).
As on December 31, 2017, Jubilant had a total of 86 ANDAs for Oral Solids filed in the US of which 56 had been approved and 12 Injectable filings of which 10 had been approved. This is the eighth USFDA approval in FY18.

Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg had annual sales of ~USD 66 million in the US as per IMS MAT Jun 2017. 

KPIT and Birlasoft to come together to create two entities
KPIT Technologies had informed the exchanges that its board had approved a draft composite scheme for amalgamation of Birlasoft (India) with KPIT. The second leg of the transaction would involve demerger of the engineering business of the company into KPIT Engineering Limited (KEL), a wholly owned subsidiary of the company and will be renamed as KPIT Technologies Limited.
According to the arrangement, shareholders of Birlasoft will receive 22 equity shares of the combined KPIT -Birlasoft for every nine equity shares of Birlasoft. the combined KPIT-Birlasoft will be engaged in the ITSS Business, and pursuant to the Proposed Demerger, KEL's shares will be listed and shareholders of combined KPIT-Birlasoft will receive one share of KEL for each share they hold in the combined KPIT-Birlasoft.

Mylan and Biocon receive positive CHMP opinion for Insulin Glargine
Biocon has announced that it, along with its partner Mylan, has received a positive opinion from Europen Medical Agency’s (EMA) - Committee for Medicinal Products for Human Use (CHMP) - for insulin Glargine. CHMP has also recommended approval to Insulin Glargine, which will be sold under brand Semglee.
There are ~60m people affected by diabetes in Europe with an increasing prevalence in the region. Insulin Glargine is a biosimilar, which will be available for commercialization once it receives EMA approval.
Biocon and Mylan are also awaiting approval for Insulin Glargine in Australia, Canada, and the US and are planned for key Emerging Markets.

Amber Enterprises lists at 38% premium to issue price
Amber Enterprises listed at a significant premium of 38% to its issue price of Rs855-859 and is currently trading at Rs1, 187.2.
The IPO offer consisted of Fresh Issue of 55.3 lakh shares (aggregating up to ~Rs475cr) at the upper end of the price band. It also includes an offer for sale of up to 14.6 lakh shares (Rs125cr) by the promoters. The issue proceeds will be used for pre-payment or repayment of borrowings (~Rs400cr) and for other general corporate purposes (~Rs75cr).

HCL Tech gets 5-year order from Cadent for IT Infra services
HCL Technologies (HCL) announced a five-year IT infrastructure services and application management contract with Cadent, the UK’s largest gas distribution network. The ground-breaking ‘cloud first’ multi-service deal will see HCL provide integrated public cloud hosting and SAP and Application Maintenance Services, including the migration of a significant applications portfolio to Amazon Web Services (AWS) public cloud. In addition, HCL will provide IT Service Management, Service Desk and Managed Workplace Services.
HCL will deliver these services to support Cadent’s business operations which distributes gas to 11 million homes and businesses in the North West, Midlands, East and South East of England. HCL will provide MWS support to approximately 4,500 staff; including 3,500 field based-engineers who work across the company’s 65 regional depots.

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647





Monday, 29 January 2018

expr:content='data:blog.blogId' itemprop='blogId'/>

Capitalstars Updates: Top Corporate News :- 29 Jan 2018

Capitalstars Updates:  Top Corporate News
Top Headlines Of The Day :- 29 Jan 2018
Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
DLF is looking to launch QIP of shares by April, 2018
Idea Cellular seeks government approval for raising FDI limit to 100%
Avenue Supermarts Ltd (DMart), up 5% after announcing Q3FY18 results, PAT up 65.8% yoy
DMart rallies 5% after announcing Q3FY18 results. In Q3FY18, its revenue grew by 22.6% yoy to Rs4, 095cr. EBITDA came in at Rs422cr, up 46.3% yoy . EBITDA margin expanded by 167bps yoy to 12.3% due to an improvement in sales mix and efficiency of centralized procurement. Adjusted PAT increased by 65.8% yoy to Rs252cr.
Board has also approved acquisition of 50.8% paid-up share capital of Avenue E-Commerce Limited for Rs49.2cr. Post-acquisition it will become wholly owned subsidiary. Heavy discounts to attract price sensitive customers and losses of the e-commerce entity will offset the margin gains.


Cipla, Aurobindo and Strides Shasun receive final approval for gViread
Cipla, Aurobindo and Strides Shasun have received final approval for their Abbreviated New Drug Application (ANDA) for Tenofovir Disoproxil Fumarate Tablets, 300mg, from the USFDA. This is a generic version of Gilead Sciences' Viread Tablets, 300mg which is indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in adults. The final approval means that product is available for immediate commercialization in the US.
Viread 300mg tablets had annual US sales of approximately $725-750mn as per IMS Health. An orange book search on USFDA website indicates that Aurobindo, Cipla, Teva, Macleods Pharmaceuticals and Strides Shasun, all have received approval for this drug on January 26, 2018. Approval for five different filers on the same day is likely to see competition for the Viread 300mg tablets.


Havells to set up a manufacturing unit in Rajasthan for an investment of Rs360cr
Havells is setting-up a new facility at Ghiloth, Neemrana, Rajasthan to manufacture consumer durables, as per the BSE filing. The total estimated cost for the project is Rs360cr (ex-land cost, as the company already owns the land), spread over a period of 3 years. The total investment will be funded through a mix of internal accruals and borrowings. Company expects to start the production from Q3FY19E.
For this investment, the company will be entitled to investment subsidy under the M-SIPS (Modified Special Incentive Package Scheme) introduced by MEITY and also for various tax/ levies and other benefits from the State Government of Rajasthan.


DLF is looking to launch QIP of shares by April, 2018
DLF is looking to launch its qualified institutional placement (QIP) of shares by April 2018, according to a media report.
DLF has already received approval from shareholders to sell 173-million equity shares, which will be determined by the formula laid down by the market regulator Securities and Exchange Board of India. The company may raise Rs4500-5000cr from the QIP.


Idea Cellular seeks government approval for raising FDI limit to 100%
Telecom operator Idea Cellular has made an application to the DIPP (Department of Industrial Policy and Promotion) for raising the FDI limit in Idea to 100%. Foreign investors holdings in Idea Cellular stood at ~27% stake as on December 2017. While 100% FDI is allowed in telecom companies, investments under the automatic route are allowed up to 49%.
At present, Idea Cellular is in the process of merging its telecom business with the Indian unit of Vodafone. As per latest industry data from Trai, Idea and Vodafone jointly have 40.5cr mobile subscribers. This would potentially give the joint entity the largest subscriber base in the Indian telecom segment. Vodafone is expected to hold around 47.5% stake in the merged entity and rest will be owned by Idea and its promoter Aditya Birla Group.


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647




Friday, 27 October 2017

expr:content='data:blog.blogId' itemprop='blogId'/>

PERFORMANCE OF THE DAY - 27 Oct 2017

STOCK FUTURES:

FUTURES INTRADAY:
BUY KPIT FUT 2ND TG 
BUY HERO MOTO FUT 1ST TG 

PREMIUM FUTURES:
BUY APOLLOTYRE FUT 2ND TG 

NIFTY FUTURES:
INDEX OPTION CALL

OPTION
BUY SUNPHARMA CALL 560 NOV 3RDTG 

OPTION PREMIUM
IOC 420 PUT NOV BUY CALL RECENT MADE HIGH OF 25.45 BOOK PARTIAL PROFIT NEAR ITCMP-25.25,AND HOLD 

STOCK CASH

STOCK CASH INTRADAY
BUY RADICO IN CASH 3RDTG 
BUY RECLTD IN CASH 1ST TG 

STOCK CASH  PREMIUM:
BUY TATAGLOBAL IN CASH HOLD FOR TOMORROW
RECLTD BOUGHT ON 25TH OCT NR 163 CALL ON FIREEEE 3RD TG ALMOST ACHIEVED, HIGH 173.25 BOOK FULL PROFIT
IRB INFRA IN CASH BUY CALL RECENT MADE HIGH OF 241.65 BOOK 50% PROFIT NEAR IT AND 2ND TG 248 ,

STOCK SUPER CASH PREMIUM
BUY UBL IN CASH BUY CALL 3RD TG 
BUY SRTRANSFIN IN CASH 2ND TG 
ENGINERSIN IN CASH ON FIREEEEEEEEEEE OUR 3RD TGT 177 ACHIEVED, BOOK FULL PROFIT NEAR TO IT,
ENGINERSIN IN CASH 2ND BUY CALL  ON FIREEEEEEEEEEE OUR 3RD TGT 187 ALMOST ACHIEVED, BOOK FULL PROFIT NEAR TO IT,

EQUITY KING CALL
MARUTI FUT NOV MADE HIGH 8097 NR FINAL TGT 8100 BOOK FULL PROFIT NR IT
ENGINERSIN FUT BOUGHT NR 157.5 FINAL TGT 160.5 ACHIEVED BOOK FULL SUPER PROFIT NR IT

OPTION STRATEGY
BUY INFY 960 CALL NOV  HOLD FOR TOMORROW

HNI CASH CALL
RADICO IN CASH BUY CALL MADE HIGH OF 228.80 BOOK PARTIAL PROFIT NEAR ITCMP-228.25, AND FINAL TG 275

HNI FUTURE CALL
BUY TVS MOTORS FUTURE NOV HOLD FOR TOMORROW

HNI OPTION CALL
MARUTI CALL 8100 BOUGHT NR 219 MADE HIGH 259.7 NR FINAL TGT 260 BOOK FULL PROFIT NR IT

CPE FUTURE CALL
BPCL NOV FUTURES BUY CALL RECENT MADE HIGH OF 545.10 BOOK 50% PROFIT NEAR IT,



Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Thursday, 20 August 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Corporate News For Today 20-Aug-2015

·         Aurobindo gets final approval for Omeprazole
Aurobindo Pharma announced that the company has received the final approval from the US Food & Drug Administration ( USFDA) to manufacture and market Omeprazole Delayed-release Capsules USP, 10mg, 20mg and 40mg. The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Prilosec® Delayed-release Capsules, 10mg, 20mg and 40mg of AstraZeneca Pharmaceuticals.

·          Aurobindo receives USFDA approval for Ibandronate
Aurobindo Pharma announced that the company has received final approvals from the US Food & Drug Administration ( USFDA) to manufacture and market Ibandronate Sodium Injection, 3mg/3mL (1mg/mL).
Ibandronate Sodium Injection, 3mg/3mL (1mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Boniva® Injection, 3mg/3mL (1mg/mL) of Hoffmann-La Roche, Inc. Ibandronate Sodium Injection is indicated for the treatment of osteoporosis in postmenopausal women.
                                                                                
·         Crude oil declines further; Brent at $47
Crude oil declined further; Brent at $47 and WTI at $ 40, new low - Positive for OMC’s , Paints, Lubricants and Tyre companies .Crude Oil ( Brent) has slipped again and is now trading below 5 year low at $ 46.92, while WTI Oil is hovering around $40. As a result the industries which use crude and its derivatives are expected to be beneficial. Positive for OMCs (HPCL, BPCL), Paint (Asian Paints) and lubricants (Castrol, Gulf oil lubricant)
·         Lupin gets USFDA nod for Fenofibrate tablets; stk jumps
Shares of Lupin surged over 8%, touching to Rs1939.9, after pharma major said it has received approval from USFDA for Fenofibrate tablets in dosages of 160 mg and 54 mg. Fenofibrate is mainly used to reduce cholesterol levels in patients at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels.

·         Ratnamani Metals bags new order worth Rs159.40 cr
Ratnamani Metals & Tubes has announced that the Company has bagged an order for supply of coated CS pipes from Reliance Gas Pipelines amounting to Rs159.40 crores (net of taxes and duties) to be completed in current financial year.

·         Somi Conveyor Beltings receives orders worth Rs40.14 cr
Somi Conveyor Beltings said that it has received purchase orders worth Rs40.137 crore from BHEL, L&T and ThyssenKrupp Industries. The company will supply conveyor belts and related material of various specifications, it said. The company has bagged order worth Rs14.751 crore from Bharat Heavy Electricals ( BHEL). The order worth Rs14.164 crore was received from Larsen & Tourbo ( L&T), it said.
In addition, ThyssenKrupp Industries India issued order worth Rs 11.222 million to the company.
                                                                                                   
·         JSW Steel to invest Rs5000 cr on capital expenditure
JSW Steel has said that it is planning to invest about Rs5,000 crore on various capital expenditure projects in this fiscal ending March 2016, as per reports.  Commenting on the issue, JSW Steel Chairman and Managing Director Sajjan Jindal told the media, 'The company is expected to invest approximately Rs 5,000 crore during FY16 on various capital expenditure programmes.'
                                                    
·         Sun Pharma gets USFDA approval for Ximino

Sun Pharma gets USFDA approval for Ximino: Positive for the company .Sun Pharma gets US FDA approval for Supplemental New Drug Application (sNDA) for Ximino. This approval further strengthens the Company’s branded dermatology portfolio in the US. It expects Ximino TM extended-release capsules to be available for patients during the fourth quarter of 2015.

Tuesday, 11 August 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Closing Bell 11-aug

CS CLOSING BELL:
NIFTY SPOT DOWN 62@8462
SENSEX DOWN 235@27866
BANK NIFTY FUTURES DOWN 259@18700
HAVE A NICE DAY!

WWW.CAPITALSTARS.COM
+917316790000

 
DAILY NIFTY SMART MOVERS
  
SCRIPTS
PRICE
VOLUME             (IN 000’S)
PRE. CLOSE
CHANGE (%)
CHANGE (Rs.)
26640.00
69.83
26027.35
2.35
612.6
1111.00
3475.43
1086.00
2.30
25.00
540.05
1288.61
530.95
1.71
9.10
415.90
895.15
409.60
1.54
6.30
2606.60
1039.39
2572.10
1.34
34.50


DAILY NIFTY TOP LAGGARDS

SCRIPTS
PRICE
VOLUME (000’S)
PRE. CLOSE
CHANGE (%)
CHANGE (Rs.)
247.50
8464.09
261.15
-5.23
-13.65
268.95
38366.45
282.75
-4.88
-13.80
368.35
9451.21
385.70
-4.50
-17.35
103.10
4656.41
107.80
-4.36
-4.70
392.05
8236.70
407.95
-3.90
-15.90


Friday, 7 August 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Opening Bell 07-Aug-2015

CS NIFTY FUTURES (AUG)  OVERVIEW:

TREND MIXED TO BULLISH
RES2:8710
RES 1:8670
SUP1:8550
SUP2:8505
----------------------------
CS BANK NIFTY FUTURES (AUGUST ) OVERVIEW:
TREND MIXED TO BULLISH
RES 2:19375
RES 1:19285
SUP1:18970
SUP2:18895
----------------------------

CS OPENING BELL:
NIFTY SPOT UP DOWN 12@8575
SENSEX DOWN 28@28275
BANK NIFTY FUTURES DOWN 62@19035

HAPPY TRADING
WWW.CAPITALSTARS.COM +917316790000

Wednesday, 5 August 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Opening Bell 05-Aug-2015

CS NIFTY FUTURES (AUG)  OVERVIEW:
TREND MIXED TO BULLISH
RES2:8650
RES 1:8605
SUP1:8525
SUP2:8475
---------------------------

CS BANK NIFTY FUTURES (AUGUST ) OVERVIEW:
TREND MIXED TO BULLISH
RES 2:19275
RES 1:19195
SUP1:18960
SUP2:18860
----------------------------

CS OPENING BELL :
NIFTY SPOT UP 47@8562
SENSEX UP 162@28227
BANK NIFTY FUTURES UP 82@19142
HAPPY TRADING
WWW.CAPITALSTARS.COM +917316790000

Tuesday, 4 August 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Opening Bell 04-Aug-2015

CS NIFTY FUTURES (AUG)  OVERVIEW:
TREND  MIXED TO  BULLISH
RES2:8650
RES 1:8605
SUP1:8525
SUP2:8495
-------------------------------
CS BANK NIFTY FUTURES (AUGUST ) OVERVIEW:
TREND  MIXED TO BULLISH
RES 2:19275
RES 1:19150
SUP1:18825
SUP2:18715
--------------------------------
CS OPENING BELL :
NIFTY SPOT UP 10@8552
SENSEX UP 47@28237
BANK NIFTY FUTURES UP 72@19032
HAPPY TRADING
WWW.CAPITALSTARS.COM +917316790000

Thursday, 23 July 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

CapitalStars : INDIAN BENCHMARKS

CapitalStars: Indian Benchmarks Updates

INDIAN BENCHMARKS  are likely to open on a flat to positive note as the global cues look mixed with SGX Nifty trading 2 points higher.                                      
                                                          
Headlines for the day: CapitalStars
Star Ferro and Cement Q1FY2016 earnings grow by 70.7% YoY
Bharti Infratel Q1FY16 earnings In line performance; appoints Citi for ADR listing
Ceat Ltd Q1FY16 results: Fall in raw material cost drives profitability                                                                           

Trend in FII flows: The FIIs were net  buyers of Rs  450.32 Cr in the cash segment on Wednesday while the DIIs were net sellers of Rs   -351.77 Cr, as per the provisional figures released by the NSE.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market CapitalStars specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.

Tuesday, 30 June 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

Nifty and Bank Nifty Summary For Today

Nifty levels:

Nifty spot close @8318
Nifty future close @8328

Today’s view on Nifty

Due to the global weakness nifty opens gap down, but good recovery from lower level. Buy on every dip that will be a good strategy 8400-8450 will be a immediate targets.  

Bank Nifty levels:  
Bank nifty spot close @18268
Bank nifty future close @18240

View on Banknifty

Good recovery from lower level buys above 18200 for the target of 18600-18800.

lMARKET COMMENTERY

Banking stocks and index heavyweights ITC, HDFC, L&T and Reliance Industries (RIL) led a strong intraday rebound for key benchmark indices today, 29 June 2015. Recovery on the domestic bourses began in early afternoon trade. Earlier during the trading session, equity benchmark indices in India had slumped as the collapse of Greek rescue talks roiled global markets. The strong intraday recovery on the domestic bourses materialised as global crude oil prices fell. The barometer index, the S&P BSE Sensex, was provisionally off 127.97 points or 0.46% to 27683.87. The broad market depicted weakness. There were more than two losers against every gainer on BSE. The BSE Mid-Cap index was off 1.37%. The BSE Small-Cap index was off 1.49%. The decline in both these indices was higher than the Sensex's decline in percentage terms.

STOCK BUZZ
Tech Mahindra fell 7.45% to Rs 483. In its business update, the company announced during trading hours today, 29 June 2015, that the company's Q1 June 2015 results have some headwinds and tailwinds which could see a risk of marginal decline in both revenue and EBITDA (earnings before interest, taxation, depreciation and amortization) margin of the company on sequential basis. Tech Mahindra said that a seasonally weak mobility business will be a drag on Q1 revenues and EBITDA of the company. H1 B visa costs will be another drag on margins, the company said. On the other hand, favourable currency movements could help both revenue and margins, the company said.

Index heavyweight and IT major Infosys fell 1.42% at Rs 991.85. The stock hit a high of Rs 999 and a low of Rs 980 in intraday trade. The company during trading hours today, 29 June 2015, announced the launch of Finacle SME Enable to help banks enhance support and service for their small and media enterprise (SME) customers. The first-of-its-kind, mobile-based financial and business management solution is exclusively designed to help SMEs not only experience banking services on the move, but also manage their business operations efficiently, Infosys said in a statement.

HOT PURSUIT


1. Meanwhile, the Reserve Bank of India (RBI) yesterday, 28 June 2015, clarified that RBI Governor Dr. Raghuram G. Rajan had not suggested at a London Business School conference on 25 June 2015 that the world risked sliding into another Great Depression as reported by sections of the media. The RBI clarified that what Rajan had said at that conference was that the policies followed by major central banks around the world were in danger of slipping into the kind of beggar-thy-neighbour strategies that were followed in the 1930s. Rajan called for new rules of the game in the international monetary system, a call that he has made before and is gaining some traction. The Great Depression was a period of great turmoil caused by many factors and not just beggar-thy-neighbor policies, according to the clarification issued by the RBI.


2. Foreign portfolio investors (FPIs) bought shares worth net Rs 328.20 crore from the secondary equity market yesterday, 25 June 2015, as per data from Central Depository Services (India). Domestic institutional investors (DIIs) sold shares worth a net Rs 8.45 crore yesterday, 25 June 2015, as per provisional data released by the stock exchanges.

OPTION STRATEGY

1. In today’s session we have seen call buying in nifty 8200 call so we can consider this as a strong support.

2. RELIANCE 1020 & 1050 CALLS were so active, stock is really in bullish move more rally is expected up to 1050.

3. ZEEL 350 calls were in action today, stock showed us gain from lower level, more buying above 340.

STOCKS TO WATCH

TITAN:  
Buy TITAN above 360 stock may show 370-380 in coming days.
ITC:
Sell ITC below 310 stock may show 300/295 in coming days. Above 310 major resistances will be 317.
SBIN: 
Buy SBIN as remain above 263 stock may show 280/290 level in coming days, below 263 major support 254.

TOP PICKS OF THE DAY

1. BUY ONGC ABOVE….? TGT…..?STOP LOSS……?
2. BUY GAIL ABOVE…..?...TARGET….?..STOPLOSS…?
3. SELL AMBUJA BELOW….? STOCK MAY SHOW 210/200 LEVEL IN COMING DAYS WITH STOP LOSS…?

Thursday, 16 April 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

INDIAN BENCHMARK REPORT : CAPITALSTARS

INDIAN BENCHMARK are likely to open on a flat note as the global cues look subdued with SGX Nifty trading 6 points higher.           

 Results on April 16, 2015 : CapitalStars

GRUH Finance, TCS, IndusInd Bank, Mindtree 

 Headlines for the day: CapitalStars

Future Group looking at strategic investment and tie up with Bharti Retail
Sun Pharma, Israel university ink pact to develop anti-cancer drugs
Government has cut petrol price by 80 paise and Diesel prices by  Rs1.30


Trend in FII flows: The FIIs were net  buyers of Rs 108 Cr in the cash segment on Wednesday while the DIIs were net sellers of Rs  -60.18 Cr, as per the provisional figures released by the NSE.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market CapitalStars we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.
For Any Query Feel Free to Contact Us... 9977499927 or visit www.capitalstars.com

Monday, 13 April 2015

expr:content='data:blog.blogId' itemprop='blogId'/>

INDIAN BENCHMARK Updates : CapitalStars

INDIAN BENCHMARK are likely to open on a flat note as the global cues look subdued with SGX Nifty trading 9 points lower.
            
Major Headlines of the day: CapitalStar
  •    SpiceJet expands fleet, inducts 3 wet-leased Boeing 737s
  •    NTPC to soon appoint MDOs to develop 5 re-alloted mines
  •    LIC ups holding in NMDC to 10%, stake valued at Rs5,440 cr

Trend in FII flows: The FIIs were net  buyers of Rs 362.79 Cr in the cash segment on Friday while the DIIs were net buyers of Rs -135.18 Cr, as per the provisional figures released by the NSE.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market CapitalStars we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX.
 

Do U Want !!!!

Our Special Services

sensex-nifty-charts

 
Blogger Templates